Immunotherapy

The Mass General Cancer Center is committed to understanding the mechanisms by which the immune system works to kill cancer.
Electron microscope image of CAR T-cell interacting with tumor cell. Image courtesy of Maus lab.
Electron microscope image of CAR T-cell interacting with tumor cell. Image courtesy of Maus lab.
Electron microscope image of CAR T-cell interacting with tumor cell. Image courtesy of Maus lab.

Progress in Immunotherapy

Thanks to the hard work of researchers, we're getting smarter about cancer. Right now, we're finding ways to use the body's own immune system to manipulate genes to solve cancer's puzzle.

Learn more about car t-cell therapies.

CAR T-Cell Therapies

The Mass General Cancer Center is an authorized treatment center for two FDA approved CAR T-cell therapies for adult patients with lymphoma, Yescarta and Kymriah.

Learn more about the Center for Cancer Immunology.

Center for Cancer Immunology

The Center for Cancer Immunology’s investigators are working to expand the use of immunotherapy, a revolutionary approach to cancer therapy.

Learn more about the Cellular Immunotherapy program.

Cellular Immunotherapy Program

The mission of the Cellular Immunotherapy Program is to invent, develop, administer, and understand engineered immune effector cells.

What is Immunotherapy?

Immunotherapy is a type of cancer treatment that uses the body’s immune system to find and attack cancer cells.

Our goal is to understand how immune responses against tumors are initiated, maintained and evaded, with the hope of improving the ability of the immune system to eradicate cancer.

Nir Hacohen, PhD
Director, Center for Cancer Immunology, Mass General Cancer Center

Contact the Cancer Center

Contact the Mass General Cancer Center to make an appointment or learn more about our programs.